Basics of Biosimilars

This is the speaker biographies for the briefing on the Basics of Biosimilars.

Sameer V. Awsare, M.D., FACP, is associate executive director for The Permanente Medical Group in charge of Pharmacy, Adult and Family Medicine, Mental Health, Risk Adjusted Coding, Revenue Cycle, Outside Medical Services, Pain Management and the Opioid Initiative. Dr. Awsare joined the Permanente Medical Group in 1993. In addition to his clinical responsibilities, he has served in a number of other roles. He is involved in resident teaching and was the Chair of the Hospital Ethics Committee. He has also been involved in Medicare coding and compliance at the medical center level. He was the Chief of medicine at our Campbell facility. He had been a member of TPMG Board of Directors from 1997-2014, and served as its secretary from 2000 to 2006. He also served as Chair of the board’s Governance Committee and the Vice Chair of the board from 2006 – 2014. He is currently the Secretary and Chair of the Governance Committee of the Mid-Atlantic Permanente Medical Group Board. Dr. Awsare is board certified in Internal Medicine. He received his B.S. in Biology, and his M.D. from the University of California, Irvine. He has served on the voluntary clinical faculty at the Stanford University of School of Medicine. Dr. Awsare is a fellow of the American College of Physicians.

Adam J. Fein, Ph.D., is chief executive officer of Drug Channels Institute. He inspires audiences to think strategically with content-rich and entertaining keynote presentations. Straightforward and understandable, Dr. Fein excels at explaining complex business and economic issues with humor and an accessible, interactive style. He then helps the audience to draw specific implications for their own companies and jobs. Dr. Fein has delivered educational programs across the country to more than 55,000 executives across a wide range of industries. Every talk is customized to meet the specific needs of the audience. He also works with smaller groups for workshops, planning sessions, high-level executive briefings, and board presentations.

Anna Hyde, M.A., is vice president of Advocacy and Access at the Arthritis Foundation. She oversees both the federal and state legislative programs, in addition to grassroots engagement. Her focus is to raise the visibility of arthritis as a public health priority, build support for federal and state legislation that ensures access to affordable, high-quality health care, and enhance patient engagement in the policy-making process. Anna previously served as senior director of Advocacy and Access, managing the federal affairs portfolio and overseeing the state advocacy team. Prior to joining the Arthritis Foundation in 2014, Anna worked as senior manager for Federal Affairs at the American Congress of Obstetricians and Gynecologists, where she managed a portfolio of issues including appropriations, physician workforce, and health IT. She began her health policy career as a Congressional Fellow for Energy and Commerce Committee members, where she drafted legislation and staffed committee activities. Anna received a B.A. in history from Southern Methodist University, and taught junior high and high school history before moving to Washington D.C. in 2007 to pursue an M.A. in political science from American University.

Jeremy Sharp is senior vice president at Waxman Strategies. He has policy experience in both the executive and legislative branches of the federal government. In his most recent stint in government he served as deputy commissioner for Policy Planning, Legislation, and Analysis at the U.S. Food and Drug Administration. Prior to that he served at the Department of Health and Human (HHS) Services as counselor to the Secretary for Science and Public Health, under both Secretary Kathleen Sebelius and Secretary Sylvia Burwell. He also served as deputy assistant secretary for Legislation at HHS. During his time in these roles, Jeremy worked on a variety of issues including prescription drug pricing, biosimilar and interchangeable product policy, tobacco control, substance abuse, mental health, food safety, drug and device regulation, pharmacy compounding, emergency preparedness, reproductive health and choice, health information technology, community health centers, health professions issues, blood, tissue, and organ donation, and biomedical research.
Before working in the executive branch, Jeremy served as legislative director for Senator Christopher J. Dodd, and as one of Senator Dodd’s professional staff members on the Senate Health, Education, Labor and Pensions Committee’s Subcommittee on Children and Families. While working for Senator Dodd, Jeremy worked on the Affordable Care Act, the Family Smoking Prevention and Tobacco Control Act, and other health legislation. He also served for five and half years as Rep. Lois Capps’ senior health policy advisor and got his start working on Capitol Hill working for Sen. Evan Bayh. Between stints working for Members of Congress, Jeremy worked for the public health non-profit Trust for America’s Health.


Sarah J. Dash, MPH, is the president and chief executive officer at the Alliance for Health Policy. She drives the mission and vision of the Alliance, as well as advances and maintains the reputation of the organization as the leading nonpartisan resource for policymakers and health leaders in an evolving health policy environment. Sarah joined the Alliance in 2014 as the vice president for policy and became president and CEO in May 2017. Sarah has long been an influential force in shaping health policy, having served as a senior aide on Capitol Hill and as a member of the research faculty at the Georgetown University Health Policy Institute’s Center on Health Insurance Reforms. Sarah holds a master’s degree in public health from the Yale School of Public Health and a bachelor’s degree in chemistry and literature from MIT. Sarah also holds an Executive Certificate in Nonprofit Management from Georgetown University.